Trial Profile
Examining the Effects of Stimulant Medication on Emotional Lability in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2019
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 09 Oct 2018 Status changed from recruiting to completed.
- 30 Mar 2018 Planned End Date changed from 1 Feb 2018 to 1 Jun 2018.
- 30 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Jun 2018.